$4.055
-0.409 (-10.09%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Aligos Therapeutics, Inc. (ALGS) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting ALGS is Strong sell.
Aligos Therapeutics, Inc. (ALGS) 20-Day simple moving average is 4.92, while Aligos Therapeutics, Inc. (ALGS) share price is $—, making it Sell.
Aligos Therapeutics, Inc. (ALGS) 60-Day simple moving average is 5.58, while Aligos Therapeutics, Inc. (ALGS) share price is $—, making it Sell.
Technical Analysis for ALGS
AI Technical ALGSAs of 2026-11-07, the technical board for Aligos Therapeutics, Inc. (ALGS) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $4.05 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 33.341, MACD stands at -0.24 (Sell), Stochastic %K stands at 18.38 (Buy), Stochastic %D stands at 22.392 and CCI stands at -191.178 (Buy).
ALGS trades below the 60-day SMA (5.58) and below the 200-day SMA (6.15). Immediate resistance sits at Classic R1 5.41, then R2 6.08. Support sits at Classic S1 4.03, then S2 3.33.
Aligos Therapeutics, Inc. (ALGS) Support & Resistance Level
Aligos Therapeutics, Inc. (ALGS) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 33.341 |
| STOCHk_14_3_3 | 18.380 |
| STOCHd_14_3_3 | 22.392 |
| CCI_20 | -191.178 |
| AO_5_34 | -0.457 |
| MOM_10 | -0.710 |
| MACD_12_26_9 | -0.240 |
Aligos Therapeutics, Inc. (ALGS) Relative Strength Index (RSI_14) is 33.341, creating a Neutral signal.
Aligos Therapeutics, Inc. (ALGS) Stochastic %K is 18.380, creating a Buy signal.
Aligos Therapeutics, Inc. (ALGS) Stochastic %D is 22.392, creating a Neutral signal.
Aligos Therapeutics, Inc. (ALGS) CCI_20 is -191.178, creating a Buy signal.
Aligos Therapeutics, Inc. (ALGS) Awesome Oscillator (AO) is -0.457, creating a Sell signal.
Aligos Therapeutics, Inc. (ALGS) Momentum (MOM) is -0.710, creating a Sell signal.
Aligos Therapeutics, Inc. (ALGS) Moving Average Convergence Divergence (MACD) is -0.240, creating a Sell signal.
Aligos Therapeutics, Inc. (ALGS) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.590 | Sell |
| MA_10 | 4.734 | Sell |
| MA_20 | 4.915 | Sell |
| MA_60 | 5.578 | Sell |
| MA_200 | 6.151 | Sell |
| MA_250 | 6.785 | Sell |
Aligos Therapeutics, Inc. (ALGS) 5-Day simple moving average is 4.590, while Aligos Therapeutics, Inc. (ALGS) share price is $, making it a Sell.
Aligos Therapeutics, Inc. (ALGS) 10-Day simple moving average is 4.734, while Aligos Therapeutics, Inc. (ALGS) share price is $, making it a Sell.
Aligos Therapeutics, Inc. (ALGS) 20-Day simple moving average is 4.915, while Aligos Therapeutics, Inc. (ALGS) share price is $, making it a Sell.
Aligos Therapeutics, Inc. (ALGS) 60-Day simple moving average is 5.578, while Aligos Therapeutics, Inc. (ALGS) share price is $, making it a Sell.
Aligos Therapeutics, Inc. (ALGS) 200-Day simple moving average is 6.151, while Aligos Therapeutics, Inc. (ALGS) share price is $, making it a Sell.
Aligos Therapeutics, Inc. (ALGS) 250-Day simple moving average is 6.785, while Aligos Therapeutics, Inc. (ALGS) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.